Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Perspectives on monoclonal antibody therapy as potential therapeutic intervention for Coronavirus disease-19 (COVID-19)
Balamurugan Shanmugaraj, Konlavat Siriwattananon, Kittikhun Wangkanont, et al.
Asian Pacific Journal of Allergy and Immunology (2020)
Open Access | Times Cited: 482

Showing 1-25 of 482 citing articles:

Potent neutralizing antibodies from COVID-19 patients define multiple targets of vulnerability
Philip J. M. Brouwer, Tom G. Caniels, Karlijn van der Straten, et al.
Science (2020) Vol. 369, Iss. 6504, pp. 643-650
Open Access | Times Cited: 1271
COVID-19: Transmission, prevention, and potential therapeutic opportunities
Melika Lotfi, Michael R. Hamblin, Nima Rezaei
Clinica Chimica Acta (2020) Vol. 508, pp. 254-266
Open Access | Times Cited: 987
Neutralizing monoclonal antibodies for treatment of COVID-19
Peter C. Taylor, Andrew C. Adams, Matthew M. Hufford, et al.
Nature reviews. Immunology (2021) Vol. 21, Iss. 6, pp. 382-393
Open Access | Times Cited: 706
COVID-19 infection alters kynurenine and fatty acid metabolism, correlating with IL-6 levels and renal status
Tiffany Thomas, Davide Stefanoni, Julie A. Reisz, et al.
JCI Insight (2020) Vol. 5, Iss. 14
Open Access | Times Cited: 521
Individual risk management strategy and potential therapeutic options for the COVID-19 pandemic
Amin Gasmi, Sàdaf Noor, Torsak Tippairote, et al.
Clinical Immunology (2020) Vol. 215, pp. 108409-108409
Open Access | Times Cited: 304
The emergence of COVID-19 as a global pandemic: Understanding the epidemiology, immune response and potential therapeutic targets of SARS-CoV-2
Shibi Muralidar, Senthil Visaga Ambi, Saravanan Sekaran, et al.
Biochimie (2020) Vol. 179, pp. 85-100
Open Access | Times Cited: 304
COVID-19 Transmission, Current Treatment, and Future Therapeutic Strategies
Vrishali S. Salian, Jessica Wright, Peter T. Vedell, et al.
Molecular Pharmaceutics (2021) Vol. 18, Iss. 3, pp. 754-771
Closed Access | Times Cited: 296
Potential effects of curcumin in the treatment of COVID‐19 infection
Fatemeh Zahedipour, Seyede Atefe Hosseini, Thozhukat Sathyapalan, et al.
Phytotherapy Research (2020) Vol. 34, Iss. 11, pp. 2911-2920
Open Access | Times Cited: 289
Current epidemiological and clinical features of COVID-19; a global perspective from China
Huilan Tu, Sheng Tu, Shiqi Gao, et al.
Journal of Infection (2020) Vol. 81, Iss. 1, pp. 1-9
Open Access | Times Cited: 278
Current pharmacological treatments for COVID‐19: What's next?
Cristina Scavone, Simona Brusco, Michele Bertini, et al.
British Journal of Pharmacology (2020) Vol. 177, Iss. 21, pp. 4813-4824
Open Access | Times Cited: 268
SARS-CoV-2 Epitopes Are Recognized by a Public and Diverse Repertoire of Human T Cell Receptors
Alina S. Shomuradova, Murad Vagida, Savely A. Sheetikov, et al.
Immunity (2020) Vol. 53, Iss. 6, pp. 1245-1257.e5
Open Access | Times Cited: 239
Plant Molecular Farming: A Viable Platform for Recombinant Biopharmaceutical Production
Balamurugan Shanmugaraj, Christine Joy I. Bulaon, Waranyoo Phoolcharoen
Plants (2020) Vol. 9, Iss. 7, pp. 842-842
Open Access | Times Cited: 202
The interplay between inflammatory pathways and COVID-19: A critical review on pathogenesis and therapeutic options
Shalki Choudhary, Kajal Sharma, Om Silakari
Microbial Pathogenesis (2020) Vol. 150, pp. 104673-104673
Open Access | Times Cited: 194
Serum Proteomics in COVID-19 Patients: Altered Coagulation and Complement Status as a Function of IL-6 Level
Angelo D’Alessandro, Tiffany Thomas, Monika Dzieciątkowska, et al.
Journal of Proteome Research (2020) Vol. 19, Iss. 11, pp. 4417-4427
Open Access | Times Cited: 191
ATR-FTIR spectroscopy and spectroscopic imaging for the analysis of biopharmaceuticals
Hannah Tiernan, Bernadette Byrne, Sergei G. Kazarian
Spectrochimica Acta Part A Molecular and Biomolecular Spectroscopy (2020) Vol. 241, pp. 118636-118636
Open Access | Times Cited: 172
Neurological Insights of COVID-19 Pandemic
Gaurav Das, Nabanita Mukherjee, Surajit Ghosh
ACS Chemical Neuroscience (2020) Vol. 11, Iss. 9, pp. 1206-1209
Open Access | Times Cited: 170
ACE2 imbalance as a key player for the poor outcomes in COVID-19 patients with age-related comorbidities – Role of gut microbiota dysbiosis
Sofia Viana, Sara Nunes, Flávio Reis
Ageing Research Reviews (2020) Vol. 62, pp. 101123-101123
Open Access | Times Cited: 170
Risk Assessment of Healthcare Workers at the Frontline against COVID-19
Saqib Ali, Sara Noreen, Imran Farooq, et al.
Pakistan Journal of Medical Sciences (2020) Vol. 36, Iss. COVID19-S4
Open Access | Times Cited: 161
Coronavirus Disease (COVID-19): Current Status and Prospects for Drug and Vaccine Development
Kevin Ita
Archives of Medical Research (2020) Vol. 52, Iss. 1, pp. 15-24
Open Access | Times Cited: 160
A narrative literature review on traditional medicine options for treatment of corona virus disease 2019 (COVID-19)
Amir Mirzaie, Mehrdad Halaji, Farhad Safarpoor Dehkordi, et al.
Complementary Therapies in Clinical Practice (2020) Vol. 40, pp. 101214-101214
Open Access | Times Cited: 154
Potential Clinical Benefits of Quercetin in the Early Stage of COVID-19: Results of a Second, Pilot, Randomized, Controlled and Open-Label Clinical Trial
Francesco Di Pierro, Somia Iqtadar, Amjad Khan, et al.
International Journal of General Medicine (2021) Vol. Volume 14, pp. 2807-2816
Open Access | Times Cited: 150
Potential therapeutic options for COVID-19: an update on current evidence
Zahra Niknam, Ameneh Jafari, Ali Golchin, et al.
European journal of medical research (2022) Vol. 27, Iss. 1
Open Access | Times Cited: 136
An update to monoclonal antibody as therapeutic option against COVID-19
Paroma Deb, Md. Maruf Ahmed Molla, KM Saif‐Ur‐Rahman
Biosafety and Health (2021) Vol. 3, Iss. 2, pp. 87-91
Open Access | Times Cited: 118
Neutrophil elastase: From mechanisms to therapeutic potential
Weilin Zeng, Yingqiu Song, Runze Wang, et al.
Journal of Pharmaceutical Analysis (2023) Vol. 13, Iss. 4, pp. 355-366
Open Access | Times Cited: 65
Nanotherapeutics for pulmonary drug delivery: An emerging approach to overcome respiratory diseases
Eknath Kole, Krishna Jadhav, Nitin Shirsath, et al.
Journal of Drug Delivery Science and Technology (2023) Vol. 81, pp. 104261-104261
Closed Access | Times Cited: 39
Page 1 - Next Page

Scroll to top